Trade Summary

4 days ago, Chan Phillip P., serving as Chief Executive Officer at Cytosorbents Corp (CTSO), purchased 261,469 shares at $0.40 per share, for a total transaction value of $104,897.59. Following this transaction, Chan Phillip P. now holds 1,744,432 shares of CTSO.

This purchase represents a 17.63% increase in Chan Phillip P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 6:24 PM ET, 3 days after the trade was made.

Cytosorbents Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.